Avalo Therapeutics (AVTX)Deep Track Capital, LP opened a new position $9.19M

967K

Shares reported

0.29%

Disclosed portfolio weight

$9.19M

Reported value

Holdings as of

Sep 30, 2024

Filed

Nov 14, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 12, 2024InsiderDirector purchased ~$6.2K of AVTX shares in the open market
2. Nov 13, 2024InsiderDirector purchased ~$6.5K of AVTX shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Avalo Therapeutics

For Avalo Therapeutics, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AVTX page.

How this filing works

• SEC Form 13F

Other disclosures at Avalo Therapeutics

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 13F-HRFeb 14, 2025

Everything OQRO holds on this company is on its AVTX page.